Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Boundless Bio, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-06-15 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-15
Exact text from the filing
Proposal 2: The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 by the votes set forth below. Votes For Votes Against Abstentions Broker Non-Votes 15,376,973 127,747 52,066 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Boundless Bio, Inc. shareholders approved Election of Class II Directors at the 2026-06-15 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-15
Exact text from the filing
Proposal 1 : Each of the director nominees was elected as a Class II director to hold office until the Company’s 2029 annual meeting of stockholders, and until their respective successor is duly elected and qualified, by the votes set forth below. Nominee Votes For Votes Withheld Broker Non‐Votes James Christensen, Ph.D. 9,287,096 512,585 5,757,105 Jennifer Lew 9,271,084 528,597 5,757,105
View on SEC.gov